AIM
PFE icon

Alhambra Investment Management’s Pfizer PFE Stock Holding History

Alhambra Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
9,260
+95
+1% +$2.48K 0.1% 165
2026
Q1 		$257K Sell
9,165
-298
-3% -$7.93K 0.12% 151
2025
Q4 		$236K Sell
9,463
-509
-5% -$12.8K 0.11% 153
2025
Q3 		$254K Sell
9,972
-6,841
-41% -$169K 0.12% 150
2025
Q2 		$408K Buy
16,813
+3,785
+29% +$88.3K 0.2% 109
2025
Q1 		$330K Sell
13,028
-233
-2% -$6.1K 0.17% 121
2024
Q4 		$352K Buy
13,261
+26
+0.2% +$705 0.18% 119
2024
Q3 		$383K Buy
13,235
+1,970
+17% +$57.5K 0.2% 119
2024
Q2 		$315K Buy
11,265
+2,265
+25% +$62.4K 0.17% 123
2024
Q1 		$250K Sell
9,000
-1,337
-13% -$37.1K 0.14% 138
2023
Q4 		$298K Sell
10,337
-3,288
-24% -$99.4K 0.18% 124
2023
Q3 		$452K Sell
13,625
-295
-2% -$10.4K 0.3% 94
2023
Q2 		$511K Sell
13,920
-9,224
-40% -$359K 0.34% 82
2023
Q1 		$944K Buy
23,144
+1,412
+6% +$61K 0.65% 43
2022
Q4 		$1.11M Sell
21,732
-126
-0.6% -$6.04K 0.81% 34
2022
Q3 		$956K Buy
21,858
+533
+2% +$25.9K 0.73% 35
2022
Q2 		$1.12M Buy
21,325
+946
+5% +$48.2K 0.81% 30
2022
Q1 		$1.05M Buy
20,379
+9,152
+82% +$475K 0.7% 35
2021
Q4 		$663K Hold
11,227
– – 0.46% 70
2021
Q3 		$483K Buy
11,227
+100
+0.9% +$4.43K 0.37% 89
2021
Q2 		$436K Buy
11,127
+185
+2% +$7.19K 0.33% 94
2021
Q1 		$396K Sell
10,942
-360
-3% -$12.8K 0.32% 98
2020
Q4 		$416K Sell
11,302
-576
-5% -$21.1K 0.44% 79
2020
Q3 		$414K Buy
11,878
+223
+2% +$7.82K 0.5% 67
2020
Q2 		$362K Sell
11,655
-391
-3% -$13.3K 0.48% 62
2020
Q1 		$373K Sell
12,046
-1,672
-12% -$57K 0.61% 43
2019
Q4 		$510K Buy
+13,718
New +$489K 0.59% 45

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Alhambra Investment Management's PFE Position: Q2 2026 in Review

Alhambra Investment Management increased its Pfizer (PFE) stake by 1% in Q2 2026, buying an estimated $2.48K and bringing the position to 9,260 shares worth $223K. The position accounts for 0.1% of the portfolio, ranked #165.

Alhambra Investment Management first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.12M in Q2 2022. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Alhambra Investment Management held 9,260 shares of Pfizer worth $223K as of Q2 2026.
  • Alhambra Investment Management bought 95 Pfizer shares in Q2 2026, an estimated $2.48K.
  • Pfizer made up 0.1% of Alhambra Investment Management's portfolio in Q2 2026, its #165 holding.
  • Alhambra Investment Management first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Alhambra Investment Management's Pfizer position peaked at $1.12M in Q2 2022.
  • 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alhambra Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.